BC
TTHI

Birchview Capital’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Birchview Capital’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-23,866
Closed -$36K – 44
2016
Q3 		$36K Sell
23,866
-121,880
-84% -$193K 0.02% 43
2016
Q2 		$214K Hold
145,746
– – 0.16% 33
2016
Q1 		$187K Hold
145,746
– – 0.13% 34
2015
Q4 		$280K Hold
145,746
– – 0.16% 34
2015
Q3 		$261K Hold
145,746
– – 0.17% 35
2015
Q2 		$306K Sell
145,746
-5,000
-3% -$35K 0.16% 33
2015
Q1 		$1.03M Hold
150,746
– – 0.54% 17
2014
Q4 		$1.03M Buy
+150,746
New +$974K 0.6% 16

Birchview Capital's TTHI Position: Q4 2016 in Review

Birchview Capital sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q4 2016, closing a stake of 23,866 shares — an estimated $36K sold.

Birchview Capital first reported a position in TTHI in Q4 2014 and held it in 8 quarters. The position peaked at $1.03M in Q4 2014. 0 funds tracked by Wall St. Rank hold TTHI as of Q4 2016.

  • Birchview Capital reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q4 2016 after selling out during the quarter.
  • Birchview Capital sold 23,866 TRANSITION THERAPEUTICS INC (CANADA) shares in Q4 2016, an estimated $36K.
  • Birchview Capital first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q4 2014 and held it in 8 quarters.
  • Birchview Capital's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $1.03M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q4 2016.

Based on Birchview Capital's 13F filing for Q4 2016, filed 9 Feb 2017.